MGI Tech Co., Ltd, a company dedicated to developing core tools and technologies that drive innovation in the life sciences, announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI's "SEQALL+GLI+Omics" strategy, positioning the company as the world's only manufacturer of core life science tools spanning short-read sequencing, long-read nanopore sequencing, generative lab intelligence and spatial omics technologies.
By bringing spatial biology and nanopore sequencing technologies fully in house, MGI strengthens its product portfolio, enhances long-term competitiveness and advances its vision of becoming a one-stop solution provider for customers' long-read and short-read sequencing needs.